Panel Discussion: Future Directions for Anti-VEGF Therapies

Time: 12:10 pm
day: Day One


  • Increasing patient response rates, not just prolonging treatment duration
  • New therapy formats (bispecifics) – how does dual-specificity open up a wide range of therapeutic applications for these multifactorial diseases?
  • Combinatorial approaches – approaches that could potentially be used on patients currently refractory or not optimally treated with anti-VEGF-A therapy alone